相关实验视频
Updated: Sep 9, 2025

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
22.0K
在急性缺血性中风中使用 Tenecteplase:来自韩国中风学会的科学声明
Hyunsoo Kim1, Joon-Tae Kim2, Beom Joon Kim3
1Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Journal of clinical neurology (Seoul, Korea)
|August 29, 2025
概括
在急性缺血性中风 (AIS) 治疗中,tenecteplase (TNK) 是一个有前途的替代药物. 这项科学声明支持TNK的采用,旨在改善患者的治疗结果.
科学领域:
- 神经学
- 心血管医学
- 药理学
背景情况:
- 甲酸 (TNK) 是一种急性缺血性中风 (AIS) 的结血剂.
- 许多地区,包括韩国,都缺乏TNK在AIS中的监管批准和补偿政策.
- 这为AIS患者创造了治疗缺口.
研究的目的:
- 关于急性缺血性中风 (AIS) 的Tenecteplase (TNK) 的政策变化.
- 支持在尚未使用的地区推出TNK.
- 为了使AIS患者能够从血栓溶解治疗的进步中受益.
主要方法:
- 在2010年1月至2024年11月期间发表的随机对照试验 (RCT),元分析和系统审查的审查.
- 仅包括评估RCT并提供TNK疗效和安全性的临床证据的元分析.
- 通过国际专家小组对陈述进行彻底审查和最终确定.
主要成果:
- 在AIS发作后4. 5小时内,用tenecteplase (TNK) 替代alteplase.
- 与阿尔特相比,TNK (0. 25 mg/ kg) 改善了大血管封闭症患者的临床结果,这些患者有资格接受血管内血栓切除术.
结论:
- 这些陈述提供了最新的临床证据,以支持TNK在尚未使用的国家的采用.
- 这些陈述的实施可以扩大AIS患者的治疗选择.
- 采用TNK可能有助于将急性中风护理实践与国际标准保持一致.
相关概念视频
Acute Coronary Syndrome I: Introduction
71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75

